Point State Capital LP Abb Vie Inc. Transaction History

Point State Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $5.37 Million - $6.83 Million	39,047 Added 100.0%	78,094 $12 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $26.3 Million - $33.5 Million	-191,220 Reduced 83.04%	39,047 $5.98 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $24.5 Million - $27.8 Million	230,267 New	230,267 $24.8 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.